PharmaCorp Rx Inc. (TSXV:PCRX)
Canada
· Delayed Price · Currency is CAD 0.450
+0.035 (8.43%)
At close: Apr 28, 2026
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 69.27 million as of April 28, 2026. Its market cap has increased by 9.37% in one year.
Market Cap
69.27M
Enterprise Value
68.80M
Revenue
17.60M
Ranking
n/a
PE Ratio
256.97
Stock Price
0.45
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 69.27M, an increase of 2,786.44%. That is a compound annual growth rate of 155.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 75.12M | -1.10% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.67B |
| Extendicare | 2.82B |
| Green Thumb Industries | 2.55B |
| Trulieve Cannabis | 2.51B |
| ME Therapeutics Holdings | 75.12M |
| Decibel Cannabis Company | 72.13M |
| Planet 13 Holdings | 70.58M |
| Vext Science | 70.29M |